Wenjin Yin
Wenjin Yin
Explore linked clinical trials.8 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Capecitabine and Cyclophosphamide (XC) as Maintenance Therapy for Advanced Breast Cancer | Advanced Breast Cancer | Recruiting | Not applicable | 2026-08-19 | NCT05876065 | |
| The Association of Lunula Status With the Efficacy and Safety of Neoadjuvant Therapy in Breast Cancer | Breast Cancer Invasive | Active, not recruiting | Not stated | 2026-05-15 | NCT07590570 | |
| The Association Between Blood Routine Parameters and Breast Cancer Prognosis | Breast Cancer Invasive | Active, not recruiting | Not stated | 2026-05-13 | NCT07584213 | |
| The Association Between Axillary Lymph Node Metastasis Patterns and Breast Cancer Prognosis | Breast Cancer Invasive | Active, not recruiting | Not stated | 2026-05-13 | NCT07283718 | |
| Adjuvant CDK4/6 Inhibitor Use in HR+/HER2- Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Recruiting | Not stated | 2025-11-19 | NCT07180056 | |
| Trastuzumab Deruxtecan in Advanced Breast Cancer | Advanced Breast Cancer | Recruiting | Not stated | 2025-11-18 | NCT07180264 | |
| Iparomlimab and Tuvonralimab (QL1706) in Patients With HR-positive, HER2-negative Advanced Breast Cancer | Advanced Breast Cancer | Recruiting | Phase 2 | 2025-11-18 | NCT07180160 | |
| Continuous or Intermittent Pyrotinib for HER2-positive Advanced Breast Cancer | Advanced Breast Cancer | Recruiting | Phase 2 | 2025-11-18 | NCT07180082 |